Tulsa Wealth Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Tulsa Wealth Advisors's EW Position: Q3 2026 in Review
Tulsa Wealth Advisors increased its Edwards Lifesciences (EW) stake by 11% in Q3 2026, buying an estimated $78.2K and bringing the position to 8,723 shares worth $753K. The position accounts for 0.1% of the portfolio, ranked #89.
Tulsa Wealth Advisors first reported a position in EW in Q4 2025 and has held it in 4 quarters since. The position peaked at $804K in Q4 2025. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Tulsa Wealth Advisors held 8,723 shares of Edwards Lifesciences worth $753K as of Q3 2026.
- Tulsa Wealth Advisors bought 880 Edwards Lifesciences shares in Q3 2026, an estimated $78.2K.
- Edwards Lifesciences made up 0.1% of Tulsa Wealth Advisors's portfolio in Q3 2026, its #89 holding.
- Tulsa Wealth Advisors first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 4 quarters since.
- Tulsa Wealth Advisors's Edwards Lifesciences position peaked at $804K in Q4 2025.
- 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Tulsa Wealth Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.